GlobeNewswire Inc.··DelveinsightDMD Pipeline Surge: 75+ Drugs in Development as 70+ Companies Race for Breakthrough Therapies
DelveInsight report reveals robust DMD pipeline with 75+ drugs in development across 70+ companies, including major players advancing gene therapy and dystrophin-targeting treatments.
RHHBYDYNBMRNKROSATOS+4clinical trialsgene therapy